Variant · Snv
CACNB2 NM_201596.3(CACNB2):c.804+40A>G
CI-VAR-00199617Explore in graph →NM_201596.3:c.804+40A>GClinVar 1244875 rs12357063
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1244875 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Uterine corpus endometrial carcinoma; Familial cancer of breast; Malignant lymphoma, large B-cell, diffuse; Uterine carcinosarcoma; Thymoma; Cholangiocarcinoma | germline | 3 | Jun 26, 2018 | clinvar |